We describe the clinical and patho logic f eatures of two benign myo epitheliomas of the parotid gland. Through 1985, only 42 other cases had been reported in the literature-i-Sv benign and three malignant. Fewer than lOa cases had been report ed through 1993. Since then, two other reports have been published. But are these tumors really rare, or are they simply not well recognized ? It is our opinion that they are not as rare as is generally believed because the number ofcase reports is increasing as patholo gists have become more aware of their existence.
Introduction
Myoepithelial cells are ec toderma lly derived con tracti le cells that act as smoot h muscle ce lls. They ca n be routinely ide ntified in many normal tissues that have secretory functio ns, such as the major and minor salivary glands, lacr imal glands , sweat glands, breasts, and the pros tate. J. 2 In a norm al gland, myoepithelial cells are located be twee n the epi thelial cells and the basal lamina of aci ni and interca lated ducts.' Some aut hors be lieve that myoepithe lia l cells playa definite role in several salivary gland tumors , such as mixed tumors, ade noid cy stic carc inomas, and salivary duct carcinomas.' Others contend that these cells play on ly a minor part in the se tumors, and they are still undecided as to whether this role is acti ve or passive.' Myoepithe liomas con sist exc lusively of myoepithelial cells, and they are likely to represent one of the two ce llular components of mixed tumors.
In this repo rt, we describe two cases of a benign myoepithe lioma of the paro tid gland. We do not believe that this entity is rare . Rat her , we believe that in general, physicians are simply unaware of its existence.
Case reports
Case 1. A 48 -year-old man complained of a swelling and pai n on the rig ht side of his face that had been present for approx imately 10 months. Examination re vea led an 8 x 5ern swelling in the area of the righ t parotid gla nd (figure I ). The growth was well demarcated, and it had a smooth external appearance. It had a moderately firm co nsistency, was fixe d to neighb oring tissues, and was slig htly pai nful on palpa tion . Despi te the large size of the lesion , the facia l nerve remained intac t, and there was no cervical lymphaden opath y.
Ultraso nography revealed a well-dem arcated 78 x 60 x 43 -mm mass . A solid co mpo nent and intern al ec hoes were found in the posterior portio n of the growth. It was de termi ned to be a cystic lesion because of the aco ustic enhancement in its pos terior. Th ere was a limited normal pare nchy ma echo in the anterior port ion of the lesion (figure 2).
The patient underwent a total parotidectomy with preservation of the facial ner ve. The main facia l nerve tru nk had passed through the mass. The ma ss was unencapsulated and con sisted of cystic and solid components (figure 3). It filled the peripharyngeal space. Pos toperati vely, there was no facia l paral ysis. Followup 9 months later revealed no evidence of disea se.
Case 2. A 25-year-old man complained of a swell ing on the rig ht side of his face of approximately 3 years ' duration . On exa minat ion, a 6 x 5-cm swe lling was observed in the area of the right parotid. It was a smoo th, mob ile mass that was lobulated at the posterior. Ultraso nog ra phy re vealed a so lid, we ll-de ma rcated 45 x 30-mm mass. The patient underwent a right parti al parotidectom y. The tumor was encapsulated. Two lymph nodes were found around the tail of the parotid gland. Th e pathologist repo rted them as a reactive lymph oid hyperplasia . At 6 months' followup, the patient was still free of disease.
Pathologic findings
Following surgery in both cases, the specimens were fixed in 10% formalin and then embedded in par affin . They were sectioned at 5 urn and stained with hematoxylin and eosin . For the immun ohistochemic al study, the strept-avidin method was perform ed on the para ffinembedded tissues. The antibodies used were those agai nst cytokera tin, vimentin, S-I 00 protein , actin, and desmin.
Macroscopic examination . Both tum ors were located in the parotid gland. In the first case, the tumor was unencapsul ated and measured 7 x 4 x 3 ern. In the second case, the tum or was encaps ulated and meas ured 4 x 4 x 3 ern. Both tum ors were soft in co nsistency and grayishwhite in color.
Microscopic examination. The encap sulated tumor was comp osed entirely ofspindle-shaped cells with small, fusiform extensions ofeosinophilic cytoplasm.The shapes of the nucl ei rang ed from ova l to elongated and vesicular; some were hyperchromatic . The tumor had 'a fasc icular cellular arra ngement with poor intercellul ar stroma (figure 4).
The unencapsulated tumor was histologically similar and con sisted prim arily of spindle-shaped cell s. In some areas, the tumor ce lls had a distinct plasm acytoid appearance. The plasmacy toid cells were characterized by eosi nophilic cyto plasm and ecce ntric, round to ova l nucl ei. The nuclei were ge nera lly hyperchromatic, occa sionally vesicular, and with inconspicuous or abse nt nucl eoli . Few ductal or acinar struc tures were present in some areas, and some of the ducts con tained eosi nop hilic material (fig ure 5 ).
There was no necrosis, cellul ar atypia, or mitosis in either tumor. Chondroid differenti ation was not identified in either neoplasm .
Immunohistochemical findings. Both tumors were stro ngly immunoreactive for cytokeratin, vime ntin, and S-I 00 protein and negat ive against antibodies to actin and desmin. Staining was diffuse and strong in both cases ( figure 6 ).
Discussion
Myoep itheliom as acco unt for fewe r than I% of all salivary gland tumors. Onl y 42 cases-39 beni gn and three maligna nt-were rep orted in the Engli sh-l anguage literature through 1985. 5 A review of the literature through 1993 yielded approxi mately 100 ca ses. Si nce then, two other reports have been published.v?In 1982, Sciu bba and Brann on reported ca ses of myoe pithelioma of the head and neck in 23 patient s (mea n age : 53 year s)." In 1985, Barnes et al repo rted a new case and reviewed the literature on the 4 1 previously reported cases (mean age : 39).5 In both reports, the sexes were equally affected. The most co mmo n locations of myoep ithelioma of the head and neck are the parotid gland and the palate.' In our two patient s, both tum ors originated in the parotid.
Parotid lesions never cause facial ner ve dysfunction or cervical lymph aden opath y, and those of the palate rarely ulcerate.' Neither of our patient s had any cervical me-
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MYOEPITHE LIOMA OF THE PAROTID GLAND : A REPORT OF TWO CAS ES
Cell type is not related to differences in biologic beh avior , recurrenc e rate , or the patient' s age. 8 • 14 Spindle-cell myo ep ithelioma must be distinguished from an extracranial meningioma, a pleomorphic adenoma, a ner ve sheath tumor, and a leiomyoma. A pla smacytoid myoepithelioma mu st be distingu ished from a plasmacytoma.' According to the Wo rld He alth Org ani zation ' s classificatioñ~i j l 1 tasta sis or faci al nerve dy sfunction, de spite the large size of their masses.
Myoepitheliomas usually range from I to 5 em in di ameter, and they are well dem arc ated, smooth, and uniforml y white, tan, or gra y. Th ey can de velop with or without a ca ps ule. Parotid myoepitheliomas are surro unded by a thin fibrou s capsule ; palatal lesion s are not. Both of our patients had larg e masses, and one of them was unencapsulated.
Microscopically, myoepitheliomas usually con sist of spindle-sha ped cells. Some consist of pla smacytoid cell s and others are made up of a combination of the two cell type s. Stell ate and clear cell variants are not common. Collagen is sp arse and chondroid areas are never found .' In our tw o cas es, the first tumor was made up of a combination of spindle-shaped and pla sm acytoid cell s, and the second tum or con sisted entirely of spindle-sh aped ce lls. Both tumors had poor intercellular stroma, but necrosi s, cellul ar atypia , and mito sis were not present. In the first tumor, few ductal or acin ar struc tures were present in some areas, and some of the ducts contained eosinophilic materi al."
In developing salivary glands, a common stem cell is resp onsibl e for the dev elopment of lum inal epithelial cell s and myoepithelium. Therefore, it should be expected th at proliferatin g neoplastic cell s in a myoepithel iom a would occasionally differentiate the se luminal cells .' ? With immunocyto chemic al techniques, myoepithelial cell s stain positiv e for cy toker atin, S-IOO protein, and act in , and they stain negati ve for desrnin .'? Normal salivary gland myo epithelial cell s stain negativ e for vimentin, '? while neoplastic myoepithel ial cell s stain po siti ve for it. I 1. 12 Th e tumors in both of our patients were stro ngly immunoreactive for cyt okeratin , vim entin, and S-IOO protein and negative against antibodies to actin and desmin. To identify myoepithelial tumors as either benign or malignant on histol ogic gro unds is difficult. The criteria for a dia gnosis of mali gn ancy are the presenc e of cyt ologic abnor ma lities, an increased mitotic rate, and particularly an inv asive growth pattern . 13 The se cr iter ia were not met in our two cases. of salivary gland tum ors, "Myoe pithe liomas are characteri zed by a more agg ressive grow th pattern than pleomorphic adeno mas."? But some autho rs have found that the biologic beha vior of myoep itheli om as app ears to para llel that of the pleom orph ic adeno ma .' Oth ers believe that myoep ith eli om as are mon om orphic va riants of mixed tu mors. Y It is our opinion, as well as that of Barn es et al' and Dardick et al," that sa livary ade no mas are part of a spec trum, with monom orphic adenom a and myoepith eliom a at the extremes and a wide rang e of pleomorphic adenoma s in between , dependin g on the type and degree of ge ne ex press ion that is coupled with neop last ic transfor mation.
Myoepit helioma occurs in most major and minor salivary gland tissues, and it is generall y a biol ogic ally benign lesion. By means of these two case reports, we have atte mpted to scrutinize this entity. Whi le myoepith eliom a has no specific clinic al features, it is accepted pathologicall y as a distin ct entity. We do not consid er it to be as rare a co ndi tio n as is ge nera lly believed becau se the numb er of case rep orts is increasing as patholog ists have become more aware of its existence .
